Open database of authors and journals




Results 1 to 13 of 13 articles found
2006

Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat

2005

Testosterone regulates PDE5 expression and in vivo responsiveness to tadalafil in rat corpus cavernosum

European Urology (9.8 ★★), 47, 409-16; discussion 416. Cite Citations
2014

Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model

2013

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction

2011

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action

2016

Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits

2009

The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction

2019

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial

2011

Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats

2011

Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)

2021

Which Drug to Discontinue 3 Months After Combination Therapy of Tadalafil plus Tamsulosin for Men with Lower Urinary Tract Symptom and Erectile Dysfunction? Results of a Prospective Observational Trial

2016

Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials

2015

Impact of cardiovascular risk factors and related comorbid conditions and medical therapy reported at baseline on the treatment response to tadalafil 5 mg once-daily in men with lower urinary tract symptoms associated with benign prostatic hyperplasia: an integrated analysis of four randomised, double-blind, placebo-controlled, clinical trials

Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and citations
Narrow Search
For searching the publication of a single author or in a journal or in a discipline, find the target category from Authors, Journals, Disciplines, respectively.
EXALY
Profiles
Fields
Search Engines
Tools